Clinical trial Recruiting at 1 site Interventional Ages 40 to 65 Women only

Smartphone-guided exercise and monitoring for early postmenopausal women

Official title: Smart Technology-Based Intervention and Monitoring of Physical and Mental Health in Early Postmenopausal Women

Run by National Cheng Kung University · NCT07131215 · Data updated 2026-11-12

This trial will test whether an 8-week, smartphone-delivered multimodal exercise program helps early postmenopausal women improve quality of life, muscle strength, and physical performance.

More Menopause trials

Quick facts

Study typeInterventional
Ages40 Years to 65 Years
SexWomen only
Enrollment90 (estimated)
SponsorNational Cheng Kung University
Academic / other
Locations1 site (Tainan)
StatusRecruiting
StartedAugust 15, 2025
Main results expectedJuly 30, 2028
Study endsJuly 31, 2028
Registry record updatedApril 14, 2026
Trial IDNCT07131215 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 45–65 who have been postmenopausal for at least 12 months and within six years of menopause, are not regularly exercising more than twice weekly, have BMI ≤ 35 kg/m², and do not have recent hormone therapy, major neurological or cardiovascular disease, or certain pelvic malignancies or surgeries.

Probably not a fit

Women who already exercise regularly, have uncontrolled cardiovascular or neurological conditions, recent hormone therapy, a BMI over 35, or a history of pelvic malignancy or major pelvic surgery are unlikely to benefit or may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional study compares an 8-week home-based multimodal exercise program delivered via a smartphone app with a supervised multimodal exercise program and an education-only arm in early postmenopausal women. Participants are women aged 45–65 who are within six years after menopause and meet inclusion and exclusion criteria. Primary outcomes include short-term changes in quality of life, muscle function, and physical performance, with longer-term follow-up to assess persistence of effects. The intervention combines strength, balance, and aerobic components with app-based monitoring and guidance.

Why it matters

Potential benefit: If successful, the program could provide a convenient, scalable way to improve quality of life, muscle strength, and long-term physical health for early postmenopausal women.

How similar studies have gone: Previous exercise trials in menopausal women have improved symptoms, muscle function, and quality of life, and early studies of app-based programs show promising short-term results though long-term evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 45 to 65-year-old postmenopausal women
* At least 12 months of amenorrhea
* Within 6 years after menopause

Exclusion Criteria:

* Exercised more than twice a week for at least 30 minutes per session
* Received hormone therapy in the past three months
* Neurological disease (e.g., spinal cord injury, multiple sclerosis, stroke) or cardiovascular diseases
* History of pelvic or prolapse surgery (excluding cesarean section)
* History of malignancy affecting the bladder, urethra, uterus, ovary, cervix, or rectum
* Using medications that could affect heart rate or mood
* Body mass index (BMI) \> 35 kg/m²

Where it's running

  • National Cheng Kung University
    Tainan, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Cyclic vs. Constant Estradiol for Brain Health in Menopause

    This study tests whether cyclic or continuous estradiol patches improve brain health and wellbeing in healthy postmenopausal adults.

    Recruiting Phase 4 University of Colorado, Denver · Aurora, Colorado · NCT07831499

  • Evaluating treatments for joint pain in menopausal women

    This study is testing whether muscle strengthening exercises, estrogen therapy, or a combination of both can help relieve joint pain in women going through menopause.

    Recruiting Phase 2/3 National University Hospital, Singapore · Singapore · NCT06530459

  • Hop extract vs soy isoflavone for menopausal symptoms

    This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.

    Recruiting Menoclinica by Palacios · Madrid, Madrid · NCT07904390

  • Resveratrol and Estrogen Receptors in Postmenopausal Women with CAD

    This study tests whether taking resveratrol is safe and can change estrogen-related markers in postmenopausal women with coronary artery disease.

    Recruiting InCor Heart Institute · São Paulo, São Paulo · NCT07865377

  • Ashoka Bark and Shatavari for Menopause

    This 12-week study tests whether a daily Ashoka Bark and Shatavari supplement helps reduce menopausal symptoms in postmenopausal women compared with a placebo.

    Recruiting Vidya USA Corporation · New Port Richey, Florida · NCT07861295

  • Lifestyle changes to ease menopausal symptoms, sleep problems, and anxiety

    Researchers are testing whether a structured lifestyle education program helps perimenopausal and postmenopausal women see fewer menopausal symptoms, better sleep, and less anxiety compared to usual care.

    Recruiting Konya Beyhekim Training and Research Hospital · Konya, Konya · NCT07860645

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.